Med24
metabolic-therapy 30. 10. 2026 • 2 min read • Reproduction (Cambridge, England) (PubMed)

Epigenetic Regulation in Polycystic Ovarian Syndrome: Mechanisms, Environmental Interactions, and Therapeutic Perspectives.

Polycystic ovary syndrome (PCOS), which has recently been proposed to be renamed polyendocrine metabolic ovarian syndrome (PMOS), is a reproductive endocrine-metabolic disorder affecting women of reproductive age. It is clinically characterized by hyperandrogenemia, ovulatory dysfunction, and polycystic ovarian...

Israelin lääkärimissio – uudet politiikat ja ratkaisut terveydenhuollon haasteisiin.

Polycystic ovary syndrome, recently proposed to be renamed polyendocrine metabolic ovarian syndrome (PMOS), is a reproductive endocrine-metabolic disorder affecting women of reproductive age. It is clinically defined by hyperandrogenemia, ovulatory dysfunction, and polycystic ovarian morphology, often accompanied by metabolic abnormalities like insulin resistance and obesity. The pathogenesis of PCOS remains complex and incompletely understood. Research indicates that epigenetic modifications are involved in the initiation and progression of the disorder. These modifications, including DNA methylation, histone modifications, and non-coding RNA regulation, alter gene expression without changing the DNA sequence. This contributes to conditions such as ovarian dysfunction, hormonal imbalance, and metabolic dysregulation. Aberrant DNA methylation affects genes involved in steroid hormone synthesis and metabolic regulation, contributing to hyperandrogenemia and insulin resistance. Histone modifications, including acetylation and methylation, alter chromatin structure and regulate genes essential for follicular development, leading to ovulatory disorders. Non-coding RNAs, such as microRNAs and long non-coding RNAs, further exacerbate the PCOS phenotype by targeting genes involved in hormone biosynthesis and insulin signaling pathways. Environmental factors, including the intrauterine environment and exposure to endocrine-disrupting chemicals, can induce abnormal epigenetic modifications and interact with genetic susceptibility, increasing the risk of PCOS. A comprehensive understanding of these mechanisms provides insights into the disorder’s etiology and a foundation for developing diagnostic biomarkers and therapeutic strategies based on epigenetic regulation.

Sponsored content

Original Scientific Source
Reproduction (Cambridge, England) (PubMed)
View Original Source
Medical Disclaimer All calculations, recommendations, and interpretations provided by this tool are for informational and educational purposes only. They do not substitute professional medical advice, diagnosis, or treatment. Always consult your physician regarding any health concerns.

Recommended Medical News

All news →
Nanotechnology-Driven 18F-FDG Imaging to Understand the Change in Insulin Sensitivity: Current Evidence, Methodological Gaps, and Translational Challenges.
metabolic-therapy

Nanotechnology-Driven 18F-FDG Imaging to Understand the Change in Insulin Sensitivity: Current Evidence, Methodological Gaps, and Translational Challenges.

Insulin resistance is an important metabolic derangement contributing to the pathogenesis of type 2 diabetes, obesity, metabolic syndrome, and other chronic diseases, underlining the requirement for techniques that enable in vivo analysis of tissue-specific glucose metabolism. 18F-fluorodeoxyglucose positron emission...

10. 11. 2026 Read article →
Cardiometabolic Abnormalities among Normal-Weight Adults: Prevalence and Associated Sociodemographic and Lifestyle Factors in a Large Spanish Cohort.
metabolic-therapy

Cardiometabolic Abnormalities among Normal-Weight Adults: Prevalence and Associated Sociodemographic and Lifestyle Factors in a Large Spanish Cohort.

BACKGROUND: Although body mass index (BMI) is widely used to assess obesity-related health risks, it may fail to detect individuals with normal weight who present with significant cardiometabolic abnormalities. This phenotype, often overlooked in clinical practice, is associated with increased risk of cardiovascular...

30. 10. 2026 Read article →
Advertisement